Related references
Note: Only part of the references are listed.Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR
Areti Strati et al.
BMC CANCER (2011)
Circulating Tumor Cell Isolation and Diagnostics: Toward Routine Clinical Use
Anja van de Stolpe et al.
CANCER RESEARCH (2011)
PIK3CA Mutations May Be Discordant between Primary and Corresponding Metastatic Disease in Breast Cancer
Jeanette Dupont Jensen et al.
CLINICAL CANCER RESEARCH (2011)
Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients
Bahriye Aktas et al.
GYNECOLOGIC ONCOLOGY (2011)
Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non-Small-Cell Lung Cancer
Matthew G. Krebs et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Single-cell genomics
Tomer Kalisky et al.
NATURE METHODS (2011)
Distinctive Responsiveness to Stromal Signaling Accompanies Histologic Grade Programming of Cancer Cells
Maria Gloria Luciani et al.
PLOS ONE (2011)
Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases
Akshal S. Patel et al.
ONCOTARGET (2011)
S100A4 and Metastasis A Small Actor Playing Many Roles
Kjetil Boye et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial
Tanja Fehm et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype
K. Ameri et al.
BRITISH JOURNAL OF CANCER (2010)
The PI3K Pathway As Drug Target in Human Cancer
Kevin D. Courtney et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Single cell analysis: the new frontier in 'omics'
Daojing Wang et al.
TRENDS IN BIOTECHNOLOGY (2010)
Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer
S. J. Cohen et al.
ANNALS OF ONCOLOGY (2009)
Selecting control genes for RT-QPCR using public microarray data
Vlad Popovici et al.
BMC BIOINFORMATICS (2009)
Molecular characterization of circulating tumor cells in large quantities of contaminating leukocytes by a multiplex real-time PCR
Anieta M. Sieuwerts et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients
Marta Pestrin et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Identification of novel tumor antigens with patient-derived immune-selected antibodies
Daniel Rodriguez-Pinto et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Immutable Functional Attributes of Histologic Grade Revealed by Context-Independent Gene Expression in Primary Breast Cancer Cells
Shanaz H. Dairkee et al.
CANCER RESEARCH (2009)
Tumor Self-Seeding by Circulating Cancer Cells
Mi-Young Kim et al.
CELL (2009)
Role of CXCR4/SDF-1α in the migratory phenotype of hepatoma cells that have undergone epithelial-mesenchymal transition in response to the transforming growth factor-β
Esther Bertran et al.
CELLULAR SIGNALLING (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device
AmirAli H. Talasaz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Kornelia Polyak et al.
NATURE REVIEWS CANCER (2009)
Transforming growth factor-β in breast cancer: too much, too late
Mary Helen Barcellos-Hoff et al.
BREAST CANCER RESEARCH (2009)
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
Bahriye Aktas et al.
BREAST CANCER RESEARCH (2009)
TGF-β mediates PTEN suppression and cell motility through calcium-dependent PKC-α activation in pancreatic cancer cells
Jimmy Y. C. Chow et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast
Kazumori Arai et al.
CURRENT CANCER DRUG TARGETS (2008)
Micrometastatic disease in breast cancer: Clinical implications
Michail Igntiadis et al.
EUROPEAN JOURNAL OF CANCER (2008)
Basal carcinoma of the breast revisited: an old entity with new interpretations
E. Korsching et al.
JOURNAL OF CLINICAL PATHOLOGY (2008)
High Throughput Gene Expression Measurement with Real Time PCR in a Microfluidic Dynamic Array
Sandra L. Spurgeon et al.
PLOS ONE (2008)
Detection, clinical relevance and specific biological properties of disseminating tumour cells
Klaus Pantel et al.
NATURE REVIEWS CANCER (2008)
RAS/ERK modulates TGFβ-regulated PTEN expression in human pancreatic adenocarcinoma cells
Jimmy Y. C. Chow et al.
CARCINOGENESIS (2007)
Oxidative stress pathways highlighted in tumor cell immortalization: association with breast cancer outcome
S. H. Dairkee et al.
ONCOGENE (2007)
Isolation and molecular profiling of bone marrow micrometastases identifies TWIST1 as a marker of early tumor relapse in breast cancer patients
Mark A. Watson et al.
CLINICAL CANCER RESEARCH (2007)
NF-κB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells:: potential involvement of ZEB-1 and ZEB-2
H. L. Chua et al.
ONCOGENE (2007)
Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status
Tanja Fehm et al.
BREAST CANCER RESEARCH (2007)
uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues
Songdong Meng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients
P Wülfing et al.
CLINICAL CANCER RESEARCH (2006)
Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells
B Willipinski-Stapelfeldt et al.
CLINICAL CANCER RESEARCH (2005)
Global gene expression profiling of circulating tumor cells
DA Smirnov et al.
CANCER RESEARCH (2005)
Circulating tumor cells predict survival in patients with metastatic prostate cancer
JG Moreno et al.
UROLOGY (2005)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
A molecular 'signature' of primary breast cancer cultures; patterns resembling tumor tissue
SH Dairkee et al.
BMC GENOMICS (2004)
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
WJ Allard et al.
CLINICAL CANCER RESEARCH (2004)
Solving the world-to-chip interface problem with a microfluidic matrix
J Liu et al.
ANALYTICAL CHEMISTRY (2003)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The epidermal growth factor receptor engages receptor interacting protein and nuclear factor-κB (NF-κB)-inducing kinase to activate NF-κB -: Identification of a novel receptor-tyrosine kinase signalosome
AA Habib et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
